# A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

> **NCT00219102** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 336 (—)

## Conditions studied

- Hypertension
- Diabetes

## Interventions

- **DRUG:** aliskiren

## Key facts

- **NCT ID:** NCT00219102
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 336 (—)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219102, "A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00219102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*